Dokter CROES: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Dokter CROES
Largest movements
- Current investments +€183,730
up €183,730 (+12.8%), from €1.4m to €1.6m
- Reserves +€162,802
up €162,802 (+12.3%), from €1.3m to €1.5m
of which Distributable reserves: +€162,802
- Gross operating margin -€4,838
down €4,838 (-2.0%), from €236,016 to €231,178
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,533,815 | €1,710,187 | +€176,372 | +11.5% |
| Fixed assets | 21/28 | €48,481 | €37,100 | -€11,381 | -23.5% |
| Tangible fixed assets | 22/27 | €48,481 | €37,100 | -€11,381 | -23.5% |
| Furniture and vehicles | 24 | €48,481 | €37,100 | -€11,381 | -23.5% |
| Current assets | 29/58 | €1,485,334 | €1,673,087 | +€187,753 | +12.6% |
| Amounts receivable within one year | 40/41 | €2,621 | €6,921 | +€4,300 | +164% |
| Other amounts receivable | 41 | €2,621 | €6,921 | +€4,300 | +164% |
| Current investments | 50/53 | €1,439,376 | €1,623,106 | +€183,730 | +12.8% |
| Cash at bank and in hand | 54/58 | €32,168 | €40,700 | +€8,532 | +26.5% |
| Deferred charges and accrued income | 490/1 | €11,169 | €2,360 | -€8,809 | -78.9% |
| Total equity and liabilities | 10/49 | €1,533,815 | €1,710,187 | +€176,372 | +11.5% |
| Equity | 10/15 | €1,529,179 | €1,691,981 | +€162,802 | +10.6% |
| Contributions | 10/11 | €166,900 | €166,900 | = | 0.0% |
| Reserves | 13 | €1,319,778 | €1,482,580 | +€162,802 | +12.3% |
| Non-distributable reserves | 130/1 | €16,690 | €16,690 | = | 0.0% |
| Reserves not available under the articles | 1311 | €16,690 | €16,690 | = | 0.0% |
| Distributable reserves | 133 | €1,303,088 | €1,465,890 | +€162,802 | +12.5% |
| Profit (loss) carried forward | 14 | €42,501 | €42,501 | = | 0.0% |
| Amounts payable | 17/49 | €4,636 | €18,206 | +€13,570 | +293% |
| Amounts payable within one year | 42/48 | €4,636 | €18,206 | +€13,570 | +293% |
| Trade debts | 44 | €1,971 | €12,978 | +€11,007 | +558% |
| Suppliers | 440/4 | €1,971 | €12,978 | +€11,007 | +558% |
| Taxes, remuneration and social security | 45 | €2,665 | €5,228 | +€2,563 | +96.2% |
| Taxes | 450/3 | €2,665 | €5,228 | +€2,563 | +96.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €12,120 | €12,489 | +€369 | +3.0% |
| Other operating charges | 640/8 | €1,256 | €1,172 | -€84 | -6.7% |
| Gross operating margin | 9900 | €236,016 | €231,178 | -€4,838 | -2.0% |
| Operating profit (loss) | 9901 | €222,640 | €217,517 | -€5,123 | -2.3% |
| Financial income | 75/76B | €18,698 | €18,698 | = | 0.0% |
| Recurring financial income | 75 | €18,698 | €18,698 | = | 0.0% |
| Financial charges | 65/66B | €2,320 | €3,008 | +€688 | +29.7% |
| Recurring financial charges | 65 | €2,320 | €3,008 | +€688 | +29.7% |
| Profit (loss) for the period before taxes | 9903 | €239,018 | €233,207 | -€5,811 | -2.4% |
| Income taxes | 67/77 | €71,254 | €70,405 | -€849 | -1.2% |
| Profit (loss) for the period | 9904 | €167,764 | €162,802 | -€4,962 | -3.0% |
| Profit (loss) for the period to be appropriated | 9905 | €167,764 | €162,802 | -€4,962 | -3.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.